| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.33M | - | |
| CEO | 411.2K | $32.69M | - | |
| CFO | 230.9K | $18.35M | - | |
| VP | 158.5K | $12.60M | - | |
| Other | 91.3K | $7.26M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Gutwerg Ori47 | SVP, Generics | Sell | 2,985 | $67.00 | $199,995.00 | -3.7% | -5.9% | -10.6% | |
| Jun 4, 2024 | Carey Stephen P.55 | SVP &CFO | Sell | 5,000 | $63.58 | $317,900.00 | -3.0% | -2.7% | -6.0% | |
| Jun 3, 2024 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $64.41 | $1,288,200.00 | -8.6% | -0.6% | -2.8% | |
| May 21, 2024 | Mutz Christopher | Head Of Rare Disease | Sell | 2,000 | $61.61 | $123,220.00 | -2.3% | -0.8% | -4.3% | |
| May 20, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 12,855 | $61.81 | $794,567.55 | -1.7% | -0.8% | -1.8% | |
| May 17, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 37,145 | $64.37 | $2,391,120.80 | -1.6% | -0.5% | -2.3% | |
| May 16, 2024 | Tannenbaum Renee P55 | Director | Sell | 2,000 | $63.87 | $127,740.00 | -9.9% | -7.2% | -5.9% | |
| May 14, 2024 | Lalwani Nikhil66 | President &CEO | Sell | 16,669 | $66.10 | $1,101,820.90 | -4.2% | -9.6% | -8.6% | |
| May 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $67.69 | $16,922.50 | -0.4% | -11.4% | -7.9% | |
| May 1, 2024 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $66.62 | $1,332,400.00 | -7.9% | -3.2% | +6.3% |